Assembly Biosciences (ASMB) Gains from Sales and Divestitures: 2019-2024
Historic Gains from Sales and Divestitures for Assembly Biosciences (ASMB) over the last 4 years, with Dec 2024 value amounting to $51,872.
- Assembly Biosciences' Gains from Sales and Divestitures rose 20.92% to $51,872 in Q4 2024 from the same period last year, while for Dec 2024 it was $51,872, marking a year-over-year increase of 20.92%. This contributed to the annual value of $51,872 for FY2024, which is 20.92% up from last year.
- According to the latest figures from Q4 2024, Assembly Biosciences' Gains from Sales and Divestitures is $51,872, which was up 20.92% from $42,898 recorded in Q4 2023.
- In the past 5 years, Assembly Biosciences' Gains from Sales and Divestitures registered a high of $347,096 during Q4 2021, and its lowest value of $42,898 during Q4 2023.
- For the 3-year period, Assembly Biosciences' Gains from Sales and Divestitures averaged around $128,285, with its median value being $99,848 (2022).
- In the last 5 years, Assembly Biosciences' Gains from Sales and Divestitures surged by 135.39% in 2020 and then crashed by 82.80% in 2023.
- Assembly Biosciences' Gains from Sales and Divestitures (Quarterly) stood at $297,133 in 2020, then climbed by 16.82% to $347,096 in 2021, then dropped by 28.15% to $249,376 in 2022, then plummeted by 82.80% to $42,898 in 2023, then increased by 20.92% to $51,872 in 2024.
- Its Gains from Sales and Divestitures stands at $51,872 for Q4 2024, versus $42,898 for Q4 2023 and $249,376 for Q4 2022.